Back to matches

We found a match

Your institution may have access to this item. Find your institution then sign in to continue.

Title

Cetus banks on interleukin

Authors

Buderi, R.

Abstract

Reports that Denmark is the first nation to approve interleukin-2, an immunostimulatory drug, developed by the California genetic engineering firm, Cetus. Cetus hopes other European countries will follow Denmark. Patent battle; Plans.

Subjects

CETUS Corp.

Publication

Nature, 1989, Vol 340, Issue 6230, p174

ISSN

0028-0836

Publication type

Academic Journal

DOI

10.1038/340174b0